Drugs

Theravance, Inc. Appoints Michael Faerm as Chief Business Officer

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 07/13/15 -- Theravance, Inc. (NASDAQ: THRX) today announced the appointment of Michael E. Faerm as Senior Vice President and Chief Business Officer. Mr. Fa ...

Clinical Ink Unveils SureSource(R) 5.9 for Remote Monitoring

PHILADELPHIA, PA and CAMBRIDGE, MA and WINSTON-SALEM, NC: SureSource 5.9 Establishes a New Standard for eSource and Risk-Based Monitoring by Simplifying the Remote Monitoring of Both DOCUMENTS and DATA ...

Serenus Biotherapeutics Names Renowned Industry Leader Skhumbuzo Ngozwana, M.D., as President

DUBLIN, IRELAND and JOHANNESBURG, SOUTH AFRICA: Appointment Comes as Company Makes Other Key Hires, Expands Sales Staff ...

Knight Amplifies Its Innovative Product Sourcing Strategy

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 07/07/15 -- Knight Therapeutics Inc. (TSX: GUD), through one of its wholly-owned subsidiaries, ("Knight") announced today that it has expanded its inno ...

Knight Creates Synergy With Sale of Neuragen(R) U.S.

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 06/26/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, announced t ...

Chivalrous Knight Does Pro Bono

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 06/26/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, announced t ...

Corcept Therapeutics Appoints Daniel Swisher to Board of Directors

MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 06/22/15 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the ...

M Pharmaceutical Inc. Names Highly-Regarded Electrical Engineer Dr. Michel Fattouche to Its Advisory Board

VANCOUVER, BRITISH COLUMBIA: Inventor and Co-Founder of Wi-LAN, Inc. Brings His Unique Combination of Pioneering Work, Research and Entrepreneurship to Canadian Biomedical Technology Company Focused on Obesity and Diabetes ...

Abba Medix Group (CSE: ABA) Announces Strategic and Advisory Engagement with Jacob Securities

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 06/17/15 -- Abba Medix Group Inc. (CSE: ABA),is pleased to announce it has engaged Jacob Securities Inc. ("JSI") in relation to proposed strategic and ...

Apply Innovative Risk Strategies to Protect Consumers and Enhance Drug Safety

PHILADELPHIA, PA: marcus evans Brings Together Heads of Drug Safety and Regulatory Affairs to Establish Effective Pharmacovigilance Strategies to Comply With the Global Regulatory Standards ...